Xinning Zhang

Title: Innovations by Xinning Zhang in Pharmaceutical Chemistry

Introduction

Xinning Zhang is a notable inventor based in Shanghai, China, recognized for his contributions to pharmaceutical chemistry. With a keen focus on developing efficient methodologies, Zhang has made significant strides in the field, particularly through the creation of novel compounds that serve as intermediates in drug synthesis.

Latest Patents

Zhang holds a patent for an intermediate of Eribulin and its preparation method. This innovation presents a detailed description of compounds characterized by specific structural formulas. The preparation method boasts several advantages, including mild reaction conditions, high selectivity, and low synthesis costs, making it highly suitable for large-scale production. The versatility of the compounds allows for various substitutes and protecting groups, which enhances their utility in pharmaceutical applications.

Career Highlights

Currently, Xinning Zhang is employed at Selection Bioscience LLC, where his expertise contributes to cutting-edge research and development in drug design. His work not only reflects his commitment to innovation but also showcases his ability to collaborate effectively with others in a diverse research environment.

Collaborations

Zhang collaborates with talented colleagues such as Fuyao Zhang and Huoming Li, who share a dedication to advancing pharmaceutical science. Together, they explore new horizons in research and contribute to impactful projects that push the boundaries of medical innovation.

Conclusion

In summary, Xinning Zhang stands out as a significant figure in his field. His patent on the intermediate of Eribulin illustrates his innovative approach to pharmaceutical chemistry, paving the way for future advancements in drug synthesis. Through his collaboration with esteemed colleagues at Selection Bioscience LLC, Zhang continues to make valuable contributions to the scientific community.